# Once Weekly GLP-1 in Persons With Spinal Cord Injury

> **NCT03292315** · PHASE4 · COMPLETED · sponsor: **James J. Peters Veterans Affairs Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Spinal Cord Injuries
- Insulin Resistance
- Pre Diabetes
- Obesity

## Interventions

- **DRUG:** Semaglutide 1MG Injection [Ozempic]
- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT03292315
- **Lead sponsor:** James J. Peters Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-16
- **Primary completion:** 2020-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03292315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03292315, "Once Weekly GLP-1 in Persons With Spinal Cord Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03292315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*